Differential Chemokine, Chemokine Receptor and Cytokine Expression in Epstein-Barr Virus-associated Lymphoproliferative Diseases

References

• Straus, S.E., Cohen, J.I., Tosato, G. and Meier, J. (1993) "Epstein—Barr virus infections: biology, pathogenesis, and management", Ann. Intern. Med. 118, 45–58.
   PubMed Web of Science ®Google Scholar
• Rickinson, A.B. (1986) "Chronic, symptomatic Epstein—Barr virus infection", Immunol. Today 7, 13–14.
   PubMedGoogle Scholar
• Straus, S.E. (1988) "The chronic mononucleosis syndrome", J. Infect. Dis. 157, 405–412.
   PubMed Web of Science ®Google Scholar
• Weiss, L.M., Movahed, L.A., Warnke, R.A. and Sklar, J. (1989) "Detection of Epstein—Barr viral genomes in Reed—Sternberg cells of Hodgkin's disease", N. Engl. J. Med. 32, 502–506.
   Web of Science ®Google Scholar
• Kawa-Ha, K., Ishihara, S., Ninomiya, T., Yumura-Yagi, K., Hara, J., Murayama, F., Tawa, A. and Hirai, K. (1989) "CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein—Barr viral DNA", J. Clin. Investig. 84, 51–55.
   PubMed Web of Science ®Google Scholar
• Purtilo, D.T., Strobach, R.S., Okano, M. and Davis, J.R. (1992) "Biology of disease. Epstein—Barr virus-associated lymphoproli-ferative disorders", Lab. Investig. 67, 5–23.
   PubMed Web of Science ®Google Scholar
• Abbas, AK., Murphy, KM. and Sher, A. (1996) "Functional diversity of helper T lymphocytes", Nature 383, 787–793.
   PubMed Web of Science ®Google Scholar
• Rollins, B.J. (1997) "Chemokines", Blood 90, 909–928.
   PubMed Web of Science ®Google Scholar
• Baggiolini, M. (1998) "Chemokines and leukocyte traffic", Nature 392, 565–568.
   PubMed Web of Science ®Google Scholar
• Sekiya, T., Miyamasu, M., Imanishi, M., Yamada, H., Nakajima, T., Yamaguchi, M., Fujisawa, T., Pawankar, R., Sano, Y, Ohta, K., Ishii, A., Morita, Y, Yamamoto, K., Matsushima, K., Yoshie, 0. and Hirai, K. (2000) "Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells", J. Immunol. 165, 2205–2213.
   PubMed Web of Science ®Google Scholar
• Patterson, BK., Czerniewski, M., Andersson, J., Sullivan, Y., Su, F., Jiyamapa, D., Burki, Z. and Landay, A. (1999) "Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes", Clin. Immunol. 91, 254–262.
   PubMed Web of Science ®Google Scholar
• Schena, M., Shalon, D., Davis, R.W. and Brown, P.O. (1995) "Quantitative monitoring of gene expression patterns with a complementary DNA microarray", Science 270, 467–470.
   PubMed Web of Science ®Google Scholar
• Heller, R.A., Schena, M., Chai, A., Shalon, D., Bedilion, T., Gilmore, J., Woolley, D.E. and Davis, R.W. (1997) "Discovery and analysis of inflammatory disease-related genes using cDNA microarrays", Proc. Natl Acad. Sci. USA 94, 2150.
   PubMed Web of Science ®Google Scholar
• Backed, S., Gelos, M., Kobalz, U., Hanski, ML., Bohm, C., Mann, B., Lovin, N., Gratchev, A., Mansmann, U., Moyer, my., Riecken, E.O. and Hanski, C. (1999) "Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array", Int. J. Cancer 82, 868–874.
   PubMed Web of Science ®Google Scholar
• Kapp, U., Yeh, W.C., Patterson, B., Elia, A.J., Kagi, D., Ho, A., Hessel, A., Tipsword, M., Williams, A., Mirtsos, C., Itie, A., Moyle, M. and Mak, T.W. (1999) "Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed—Sternberg cells", J. Exp. Med. 189, 1939–1945.
   PubMed Web of Science ®Google Scholar
• Ohshima, K., Suzumiya, J., Sugihara, M., Nagafuchi, S., Ohga, S. and Kikuchi, M. (1998) "Clinicopathological study of severe chronic active Epstein—Barr virus infection that develop in association with lymphoproliferative disorder and/or hemophago-cytic syndrome", Pathol. Intern. 48, 934–943.
   PubMed Web of Science ®Google Scholar
• Ohshima, K., Suzumiya, J., Sugihara, M., Nagafuchi, S., Ohga, S. and Kikuchi, M. (1999) "CD95 (Fas) ligand expression of Epstein—Barr virus (EBV)-infected lymphocytes: a possible mechanism of immune evasion in chronic active EBV infection", Pathol. Intern. 49, 9–13.
   PubMed Web of Science ®Google Scholar
• Teruya-Feldstein, J., Jaffe, ES., Burd, P.R., Kingma, D.W., Setsuda, J.E. and Tosato, G. (1999) "Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia", Blood 93, 2463–2470.
   PubMed Web of Science ®Google Scholar
• Eisen, MB. and Brown, P.O. (1999) "DNA arrays for analysis of gene expression", Methods Enzymol. 303, 179–205.
   PubMed Web of Science ®Google Scholar
• Raab-Traub, N. and Flynn, K. (1986) "The structure of the termini of the Epstein—Barr virus as a marker of clonal cellular proliferation", Cell 47, 883–889.
   PubMed Web of Science ®Google Scholar
• Kawa-Ha, K. (2000) "Epstein—Barr virus-associated diseases in humans", Int. J. Hematol. 71, 108–117.
   PubMed Web of Science ®Google Scholar
• Callan, M.F.C., Steven, N., Krausa, P., Wilson, J.D., Moss, RA., Gillespie, G.M., Bell, J.I., Rickinson, A.B. and McMichael, A.J. (1996) "Large clonal expansion of CD8+ T cells in acute infectious mononucleosis", Nat. Med. 2, 906–911.
   PubMed Web of Science ®Google Scholar
• Rickinson, E.C., Lee, S.P. and Steven, N.M. (1996) "Cytotoxic T-lymphocyte responses to Epstein—Barr virus", Curr. Opin. Immunol. 8, 492–497.
   PubMed Web of Science ®Google Scholar
• Steigerwald-Mullen, P., Kurilla, M.G. and Braciale, T.J. (2000) "Type 2 cytokines predominate in the human CD4+ T-lymphocyte response to Epstein—Barr virus nuclear antigen 1", J. Virol. 74, 6748–6759.
   PubMed Web of Science ®Google Scholar
• Ogawa, K., Tanaka, K., Ishii, A., Nakamura, Y, Kondo, S., Sugamura, K., Takano, S., Nakamura, M. and Nagata, K (2001) "A novel serum protein that is selectively produced by cytotoxic lymphocytes", J. Immunol. 166, 6404–6412.
   PubMed Web of Science ®Google Scholar
• Jundt, F., Anagnostopoulos, I., Bommert, K., Emmerich, E, Muller, G., Foss, H.D., Royer, H.D., Stein, H. and Dorken, B. (1999) "Hodgkin/Reed—Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils", Blood 94, 2065–2071.
   PubMed Web of Science ®Google Scholar
• Bud, C., Korner, M., Scharli, P., Cefai, D., Uguccioni, M., Mueller, C., Laissue, J.A. and Mazzucchelli, L. (2001) "CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease", Blood 97, 1543–1548.
   PubMed Web of Science ®Google Scholar
• van den Berg, A., Visser, L. and Poppema, S. (1999) "High expression of the CC chemokine TARC in Reed—Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma", Am. J. Pathol. 154, 1685–1691.
   PubMed Web of Science ®Google Scholar
• Ohshima, K., Akaiwa, M., Umeshima, R., Suzumiya, J., Izuhara, K. and Kikuchi, M. (2001) "Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involve-ment in fibrosis", Histopathology 38, 368–375.
   PubMed Web of Science ®Google Scholar
• Akashi, K. and Mizuno, S. (2000) "Epstein—Barr virus-infected natural killer cell leukemia", Leuk. Lymphoma 40, 57–66.
   PubMed Web of Science ®Google Scholar
• Ho, J.W., Liang, R.H. and Srivastava, G. (1999) "Differential cytokine expression in EBV positive peripheral T cell lymphomas", Mol. Pathol. 52, 269–274.
   PubMedGoogle Scholar
• Teruya-Feldstein, Jaffe, E.S., Burd, P.R., Kanegane, H., Kingma, D.W., Wilson, W.H., Longo, D.L. and Tosato, G. (1997) "The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein—Barr virus-positive lymphoproliferative disease", Blood 90, 4099–4105.
   PubMed Web of Science ®Google Scholar
• Ishihara, S., Okada, S., Waldguchi, H., Kurashige, T., Hirai, K. and Kawa-Ha, K. (1997) "Clonal lymphoproliferation following chronic active Epstein—Barr virus infection and hypersensitivity to mosquito bite", Am. J. Hematol. 54, 275–281.
   Web of Science ®Google Scholar
• Craig, MV., Clare, N., Skar, J.L. and Banks, P.M. (1992) "T-cell lymphoma and virus-associated hemophagocytic syndrome", Am. J. Clin. Pathol. 97, 189–194.
   PubMed Web of Science ®Google Scholar
• Kawa-Ha, K., Franco, E., Doi, S., Yamura, K., Tawa, A. and Yabuuchi, H. (1987) "Successful treatment of chronic active Epstein—Barr virus infection with recombinant interleukin-2", Lancet i, 154.
   Google Scholar
• Ishida, Y, Yokota, Y., Tauchi, H., Fukuda, M., Takaoka, T., Hayashi, M. and Matsuda, H. (1993) "Ganciclovir for chronic active Epstein—Barr virus infection", Lancet 341, 560–561.
   PubMed Web of Science ®Google Scholar
• Sakai, Y, Ohga, S., Tonegawa, Y, Takada, H., Nakao, F., Nakayama, H., Aoki, T., Yamamori, S. and Hara, T. (1998) "Interferon-alpha therapy for chronic active Epstein—Barr virus infection: potential effect on the development of T-Iymphoproli-ferative disease", J. Pediatr Hematol. Oncol. 20, 342–346.
   PubMed Web of Science ®Google Scholar
• Tsuge, I., Morishima, T., Kimura, H., Kuzushima, K. and Matsuoka, H. (2001) "Impaired cytotoxic T lymphocyte response to Epstein—Barr virus-infected NK cells in patients with severe chronic active EBV infection", J. Med. Virol. 64, 141–148.
   PubMed Web of Science ®Google Scholar
• Setsuda, J., Teruya-Feldstein, J., Harris, Ni., Ferry, J.A., Sorbara, L., Gupta, G., Jaffe, ES. and Tosato, G. (1999) "Interleukin-18, Interferon-gamma, IP-10, and Mig expression in Epstein—Barr virus-induced infectious mononucleosis and post-transplant lymphoproliferative disease", Am. J. Pathol. 155, 257–265.
   PubMed Web of Science ®Google Scholar
• Cohen, P.A., Peng, L., Plautz, G.E., Kim, K.K., Weng, D.E. and Shu, S. (2000) "CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection", Grit. Rev. Immunol. 20, 17.
   PubMed Web of Science ®Google Scholar